Novavax Inc
NASDAQ:NVAX
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.76
20.97
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Novavax Inc
Wall Street
Price Targets
NVAX Price Targets Summary
Novavax Inc
According to Wall Street analysts, the average 1-year price target for
NVAX
is 17.75 USD
with a low forecast of 9.09 USD and a high forecast of 26.25 USD.
NVAX Last Price Targets
Novavax Inc
The latest public price target was made on Nov 18, 2024 by
Mayank Mamtani
from
B.Riley Financial
,
who expects
NVAX
stock to
rise by 136%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Mayank Mamtani
B.Riley Financial
|
22
USD
Upside 136% |
1 week ago
Nov 18, 2024
|
Novavax (NVAX) PT Lowered to $22 at B.Riley
StreetInsider
|
Roger Song
Jefferies
|
25
USD
Upside 168% |
1 month ago
Oct 16, 2024
|
Novavax (NVAX) PT Lowered to $25 at Jefferies
StreetInsider
|
Alec Stranahan
Bank of America Securities
|
14
USD
Upside 50% |
1 month ago
Oct 16, 2024
|
Novavax (NVAX) PT Lowered to $14 at BofA Securities 'to reflect delays in phase 3 CIC/standalone flu trial'
StreetInsider
|
|
Roger Song
Jefferies
|
31
USD
Upside 233% |
4 months ago
Jul 19, 2024
|
Novavax price target lowered to $31 from $38 at Jefferies
TheFly
|
|
Vernon Bernardino
H.C. Wainwright
|
19
USD
Upside 104% |
6 months ago
May 10, 2024
|
H.C. Wainwright reiterates Buy rating on Novavax after 'landmark' Sanofi deal
TheFly
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NVAX's stock price target?
Price Target
17.75
USD
According to Wall Street analysts, the average 1-year price target for
NVAX
is 17.75 USD
with a low forecast of 9.09 USD and a high forecast of 26.25 USD.
What is Novavax Inc's Revenue forecast?
Projected CAGR
-12%
For the last 8 years the
compound annual growth rate for
Novavax Inc's revenue is
51%.
The projected
CAGR
for the next 3 years is
-12%.
You don't have any saved screeners yet
